Our study aimed to characterize fasting plasma glucagon levels in healthy individuals and both patients with T1D and T2D using a highly specific and sensitive glucagon assay (dual antibody double sandwich ELISA) and a conventional radioimmunoassay (RIA using only one antibody). The gene discussed is GCG; the disease is type 2 diabetes mellitus.